BETA

4 Amendments of Alexander BERNHUBER related to 2020/2071(INI)

Amendment 45 #
Motion for a resolution
Recital A a (new)
Aa. whereas medicine shortages are a growing public health threat with a serious impact on health care systems and public health;
2020/06/08
Committee: ENVI
Amendment 91 #
Motion for a resolution
Recital C
C. whereas the loss of European sovereignty and independence in the health sector is linked to the relocation of production, with 40% of medicinal end products marketed in the EU now originating in third countries; whereas the onlyone way to save money is to rely heavily on subcontractors to produce pharmaceutical raw materials in Asia, where labour costs and environmental standards are lower, with the result that 80% of active ingredients are manufactured outside the EU, mainly in China and India;
2020/06/08
Committee: ENVI
Amendment 157 #
Motion for a resolution
Recital G
G. whereas, in the absence of a regulatory authority, stockpiling in some Member States is leading to a market imbalance excessive stockpiling can lead to a market imbalance if cooperation between Member States is insufficient;
2020/06/08
Committee: ENVI
Amendment 187 #
Motion for a resolution
Recital J a (new)
Ja. whereas a strong, innovative and competitive pharmaceutical industry in Europe is in the vital interest of the EU and its Member States;
2020/06/08
Committee: ENVI